Agilent Technologies, Inc. $A Shares Purchased by OFI Invest Asset Management

OFI Invest Asset Management raised its position in Agilent Technologies, Inc. (NYSE:A) by 66.9% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 883 shares of the medical research company’s stock after purchasing an additional 354 shares during the period. OFI Invest Asset Management’s holdings in Agilent Technologies were worth $104,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of A. Stone House Investment Management LLC acquired a new stake in Agilent Technologies in the first quarter valued at $30,000. Opal Wealth Advisors LLC purchased a new position in Agilent Technologies during the first quarter worth about $31,000. Ransom Advisory Ltd purchased a new position in Agilent Technologies during the first quarter worth about $32,000. Central Pacific Bank Trust Division purchased a new position in Agilent Technologies during the second quarter worth about $33,000. Finally, Zions Bancorporation National Association UT purchased a new position in shares of Agilent Technologies in the 1st quarter worth about $38,000.

Agilent Technologies Stock Down 2.5%

Shares of Agilent Technologies stock opened at $136.62 on Monday. The business’s fifty day moving average price is $125.04 and its two-hundred day moving average price is $117.02. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The company has a market capitalization of $38.73 billion, a P/E ratio of 32.07, a PEG ratio of 4.46 and a beta of 1.26. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm’s revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.7%. Agilent Technologies’s payout ratio is presently 23.24%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. Robert W. Baird raised their price objective on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. Evercore ISI lifted their target price on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. Barclays lifted their target price on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 2nd. Finally, Wells Fargo & Company raised their price target on Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, September 15th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $148.69.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.